Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach problems are the most common thing people experience when they start Wegovy. Semaglutide slows how quickly food leaves your stomach, which is part of why it reduces appetite — but that same mechanism can cause nausea, discomfort and other gut symptoms, particularly in the first few weeks. These reactions are well-documented in clinical data and usually ease with time. That said, some symptoms deserve prompt medical attention, and knowing the difference matters. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've just started Wegovy, your pen is sitting in the fridge door, and two days after your first injection you feel queasy from mid-morning onwards. You're not imagining it, and you haven't done anything wrong. Semaglutide works partly by activating GLP-1 receptors in the gut wall and slowing gastric emptying, food stays in your stomach longer, which curbs hunger signals but also leaves many people feeling full to the point of nausea, or noticing that their digestion feels sluggish.
The most frequently reported stomach issues on Wegovy include nausea, vomiting, diarrhoea, constipation, bloating, indigestion and burping. Fatigue and headaches can accompany the GI symptoms, particularly in the first week or two. These effects tend to peak in the 24–72 hours after each injection, then fade as the week goes on. When the dose increases, the pattern often repeats briefly before settling again. The NHS medicines page for semaglutide lists these as recognised common effects and notes that they generally improve with time. Most people find the nausea is manageable rather than debilitating, and that eating smaller portions (particularly lower-fat, lower-spice meals) helps considerably during the adjustment period.
If you're finding the symptoms harder to tolerate, that's a conversation worth having with your prescriber before adjusting anything yourself. Holding a dose increase for an extra week, for instance, is a clinical decision rather than something to act on independently.
Mild gut upset is expected; a few things are not. Severe stomach pain that builds gradually and radiates through to your back (particularly when it comes with vomiting and doesn't ease) is the red-flag pattern for acute pancreatitis. This is a rare but serious condition. In January 2026 the MHRA issued a formal Drug Safety Update confirming acute pancreatitis as a known, infrequent side effect of GLP-1 receptor agonist medicines, urging anyone on these treatments to seek urgent care if they experience that specific pain pattern. You can read the full guidance and report any suspected reaction through the MHRA Yellow Card scheme.
Gallbladder problems are also associated with rapid weight loss in general and have been seen in semaglutide trials: upper-right abdominal pain, particularly after eating, can indicate gallstones or gallbladder inflammation and warrants medical assessment. Severe or prolonged vomiting that leaves you unable to keep fluids down risks dehydration and should not be managed at home without speaking to a clinician. Signs of an allergic reaction (swelling, rash, difficulty breathing) require emergency care.
For context on the broader picture of issues reported with Wegovy, including non-GI side effects, our full overview covers what the clinical literature documents across the treatment course. There's also specific detail on stomach ache on Wegovy for readers whose main concern is localised abdominal pain rather than wider GI disturbance.
There is no single fix, but several practical adjustments consistently help. Eating slowly and stopping well before you feel completely full takes pressure off a stomach that is already emptying more slowly than usual. Smaller, more frequent meals tend to suit people better than two or three large ones. Fatty, fried or heavily spiced food tends to worsen nausea on semaglutide, so keeping meals relatively plain during the adjustment period is sensible. Staying well hydrated matters, particularly if diarrhoea is the dominant symptom.
Timing your injection relative to your weekly routine can also make a difference, some people find injecting on a day when they can rest the following morning more manageable than doing it before a demanding work day. The question of whether Wegovy can cause stomach issues specific to the injection itself (rather than the medicine's systemic effect) is worth noting: injection-site reactions are separate from GI symptoms and are usually mild localised redness or discomfort.
If you're weighing up how stomach side effects compare between treatments, the semaglutide overview sets out the mechanism and trial profile in more depth, and the general weight-loss treatment page covers how different licensed options compare in terms of tolerability. On the question of cost and access, private treatment pricing is explained transparently on our Wegovy access page, useful if you're deciding between treatment routes. For anyone uncertain whether their current symptoms are within the expected range, common semaglutide issues gives further detail, and our support team is available seven days a week.
Some people notice their gut symptoms actually worsen briefly after stopping semaglutide, gastric emptying returns to its baseline speed, which can cause a different kind of digestive disruption as your system readjusts. Appetite often returns more strongly, too. Whether to pause, reduce or stop treatment is always a clinical decision. If you're considering this, a prescriber can advise on the safest way to approach it; there is specific information on stomach issues after stopping semaglutide for people already through that transition.
Wegovy is a prescription medicine, and every repeat supply at nume involves a fresh clinical review, not an automatic renewal. If your stomach symptoms have been persistent or severe, that review is the right moment to raise it. Our clinical team reviews consultations personally, a real prescriber, reading your answers. If you'd like to discuss your suitability or have ongoing concerns about side effects, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.